Bacillus amyloliquefaciens SC06 Relieving Intestinal Inflammation by Modulating Intestinal Stem Cells Proliferation and Differentiation via AhR/STAT3 Pathway in LPS-Challenged Piglets

J Agric Food Chem. 2024 Mar 27;72(12):6096-6109. doi: 10.1021/acs.jafc.3c05956. Epub 2024 Mar 14.

Abstract

Bacillus amyloliquefaciens is a well-accepted probiotic, with many benefits for both humans and animals. The ability of intestinal stem cells (ISCs) to develop into several intestinal epithelial cell types helps accelerate intestinal epithelial regeneration. Limited knowledge exists on how bacteria regulated ISCs proliferation and regeneration. Our study investigated the effects of Bacillus amyloliquefaciens supplementation on ISC proliferation and regeneration and intestinal mucosal barrier functions in piglets exposed to lipopolysaccharide (LPS). Eighteen piglets (male, 21 days old) were randomly split into 3 clusters: CON cluster, LPS cluster, and SC06+LPS cluster. On day 21, 100 μg/kg body weight of LPS was intraperitoneally administered to the SC06+LPS and LPS groups. We found SC06 supplementation maintained the intestinal barrier integrity, enhanced intestinal antioxidant capacity, reduced generation of inflammatory response, and suppressed enterocyte apoptosis against the deleterious effects triggered by LPS. In addition, our research indicated that the SC06 supplementation not only improved the ISC regeneration, but also resulted in upregulation of aryl hydrocarbon receptor (AhR) in LPS-challenge piglets. Further studies showed that SC06 also induced ISC differentiation toward goblet cells and inhibited their differentiation to intestinal absorptive cells and enterocytes. The coculture system of SC06 and ileum organoids revealed that SC06 increased the growth of ISCs and repaired LPS-induced organoid damage through activating the AhR/STAT3 signaling pathway. These findings showed that SC06, possibly through the AhR/STAT3 pathway, accelerated ISC proliferation and promoted epithelial barrier healing, providing a potential clinical treatment for IBD. Our research demonstrated that SC06 is effective in preventing intestinal epithelial damage after pathological injury, restoring intestinal homeostasis, and maintaining intestinal epithelial regeneration.

Keywords: Bacillus amyloliquefaciens SC06; intestinal epithelia; intestinal stem cells; organoids, AhR/STAT3 signal pathway; proliferation and differentiation.

MeSH terms

  • Animals
  • Bacillus amyloliquefaciens* / metabolism
  • Cell Proliferation
  • Humans
  • Inflammation / metabolism
  • Intestinal Mucosa / metabolism
  • Lipopolysaccharides* / pharmacology
  • Male
  • Receptors, Aryl Hydrocarbon / metabolism
  • STAT3 Transcription Factor / metabolism
  • Stem Cells / metabolism
  • Swine

Substances

  • Lipopolysaccharides
  • Receptors, Aryl Hydrocarbon
  • STAT3 protein, human
  • STAT3 Transcription Factor